Company registration number 08771706 (England and Wales)
CHOLESTENIX LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023
PAGES FOR FILING WITH REGISTRAR
CHOLESTENIX LIMITED
BALANCE SHEET
AS AT 30 NOVEMBER 2023
30 November 2023
- 1 -
2023
2022
£
£
£
£
Fixed assets
1
1
Current assets
563
35
Creditors: amounts falling due within one year
(132,909)
(120,126)
Net current liabilities
(132,346)
(120,091)
Total assets less current liabilities
(132,345)
(120,090)
Net liabilities
(132,345)
(120,090)
Capital and reserves
(132,345)
(120,090)
Notes to the financial statements
1
Employees
The average number of persons, including directors, employed by the company during the year was as follows:
2023
2022
Number
Number
Employees
2
2
2
Going Concern
At the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements
Cholestenix Limited is a private company limited by shares incorporated in England and Wales. The registered office is C/O Azets, Charter Court, Swansea Enterprise Park, Swansea, United Kingdom, SA7 9FS.
For the year ended 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
CHOLESTENIX LIMITED
BALANCE SHEET (CONTINUED)
AS AT 30 NOVEMBER 2023
30 November 2023
- 2 -
(e) the company has relied on the specified exemption as a micro company contained in section 352 Companies Act 2014; the company has done so on the grounds that it is entitled to the benefit of that exemption as a small company and we confirm that the abridged financial statements have been properly prepared in accordance with section 353 Companies Act 2014.true
The financial statements were approved by the board of directors and authorised for issue on 5 September 2024 and are signed on its behalf by:
Dr J R Normanton
Director
Company registration number 08771706 (England and Wales)